Phase 3, randomized, placebo-controlledstudy of stereotactic body radiotherapy (SBRT) with orwithout pembrolizumab in patients with inoperable stageI/IIA non-small-cell lung cancer (NSCLC): KEYNOTE-867

Category Primary study
JournalCancer Research
Year 2020
This article has no abstract
Epistemonikos ID: 1c1f0ada89bdc05eeae8a172b946ecdd720caff3
First added on: Feb 12, 2025